News
Latest News About Asthma, Allergies, and Related Conditions
AAFA can connect you to all of the information and resources you need. We provide the latest information about asthma and allergic diseases in a variety of formats. You can sign up to follow our blogs or receive our newsletters. To stay up to date on the Foundation’s announcements, check out our press releases as well.
If you are a member of the press, and need to speak with an asthma or allergy expert for your story, please contact a member of AAFA’s communications team at (202) 974-1223 or email gro.afaa@aidem.
Press Releases
AAFA Statement on EPA Cars Rule
News"A zero emissions future will make breathing easier for people with asthma” Washington, D.C., March 20, 2024 – The Asthma and Allergy Foundation of America (AAFA) applauds a new rule by the Environmental Protection Agency (EPA) that will drive...
AAFA Statement in Response to AstraZeneca Asthma Inhaler Cost Announcement
NewsPatient advocacy group continues push to reduce costs, improve access Washington, D.C., March 18, 2024 – The Asthma and Allergy Foundation of America (AAFA) welcomes efforts to make asthma medicines more affordable and accessible. AAFA continues...
Report: Climate Change Makes Living with Allergies a Challenge
NewsAAFA’s 2024 Allergy Capitals™ report names most challenging cities for living with allergies Washington D.C., March 14, 2024 — The Asthma and Allergy Foundation of America (AAFA) released its 2024 Allergy Capitals™ report detailing the most...
AAFA Statement on Asthma Inhaler Price Caps
NewsPatient advocacy group applauds efforts to make asthma medicine more affordable Washington, D.C., March 8, 2024 – The Asthma and Allergy Foundation of America (AAFA) is leading advocacy efforts to change the drug pricing ecosystem and to make...
AAFA Statement on Uber Eats Super Bowl Ad
NewsPatient advocacy group calls on Uber to be a friend to the food allergy community Washington, D.C., February 8, 2024 – The Asthma and Allergy Foundation of America (AAFA) issued the following statement which may be attributed to Kenneth Mendez,...
AAFA Applauds Senate Investigation into Pricing of Asthma Inhalers
NewsPatient advocacy group calls for action to break down barriers that prevent access to and limit affordability of asthma treatment Washington D.C. – January 9, 2024 The Asthma and Allergy Foundation of America (AAFA) today applauded the...
AAFA Joins Advocates on Capitol Hill in Support of Dillon’s Law and Expanded Access to Epinephrine
NewsLaw would improve access to life-saving medical treatment Washington, D.C. – This week, the Asthma and Allergy Foundation of America (AAFA) is proud to join the unwavering advocacy efforts of Angel and George Mueller, parents of Dillon Mueller,...
AAFA’s Statement Regarding the FDA Decision on Needle-Free Epinephrine Nasal Spray
NewsWashington D.C., September 20, 2023 — The Asthma and Allergy Foundation of America (AAFA) is disappointed that the epinephrine nasal spray known as neffy did not receive FDA approval but understands the agency is requesting additional data....
Report: Ragweed Pollen Part of “Perfect Storm” of Asthma Peak Month
NewsAAFA’s 2023 Asthma Capitals™ report highlights urgency of climate crisis Washington D.C., September 18, 2023 — The Asthma and Allergy Foundation of America’s (AAFA) 2023 Asthma Capitals™ report calls attention to the climate crisis, noting that...
New Report Reveals Most Challenging Cities to Live in the U.S. With Asthma
NewsAAFA’s 2023 Asthma Capitals™ report highlights key issues impacting people with asthma and how to take action Washington D.C., September 7, 2023 — Today, the Asthma and Allergy Foundation of America (AAFA) released its 2023 Asthma Capitals™...
